Friday, February 12, 2021
Some product liability suits are dead on arrival. At least, that is the position the Fifth Circuit took late last week in affirming the dismissal of a pro se plaintiff’s suit against a collection of generic and brand-name drug manufacturers.
The case in question is
Johnson v. Novartis Pharmaceuticals Corporation, et al., and concerns Mr. Johnson’s purported struggles with Peyronie’s Disease (PD), a connective tissue disorder that causes painful, bent erections, after he had ingested generic forms of the prescription drugs Minocin (an antibiotic) and Tegretol (an anticonvulsant).
By way of background, in April 2013, Mr. Johnson began taking generic Minocin (Minocycline) on the advice of his dermatologist. Roughly a year later, Mr. Johnson began developing symptoms of PD. His PD symptoms improved some eighteen months later, following his decision to discontinue Minocycline. A few years later, in June 2017, Mr. Johnson began taking generic
Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences
HYDERABAD, India, Feb. 11, 2021 /PRNewswire/ Sai Life Sciences, one of India s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced the addition of Dr. Mahavir Prashad, an acknowledged scientific leader and industry veteran, to its scientific leadership team as Vice President of Early Phase Process Development. With over three decades of experience in advanced research, and roles of increasing responsibility in one of the world s leading pharmaceutical companies, Dr. Prashad will provide impetus to Sai Life Sciences growing capabilities and help accelerate the drug development programmes of its customers.
Permission granted by ShantaQuilette Carter-Williams.
At 42, ShantaQuilette Carter-Williams never saw herself as someone who had a heart problem. She was active, paid attention to what she ate and felt healthy.
But one day, while on her usual run, she felt her heart flutter and went to the doctor. Six years later, after several trips to the emergency room and misdiagnoses, she had a heart attack and a stroke. Thatâs when she learned she had cardiovascular disease, which can lead to both. She also was surprised to learn that it runs in her family â her mother had suffered a heart attack at a young age and hadnât told her about it.
a2zJanuary 29, 2021 15
Paroxysmal Choreoathetosis Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.
Paroxysmal choreoathetosis is a disorder characterized by movement disorder occurring due to episodes of involuntary movements in limbs, facial and trunk muscles. This disorder being genetic may occur in several members of a genetically connected family or may occur only in a single member of the family. The gene responsible for the disorder was found to be associated with the epilepsy as well.